Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited life-threatening arrhythmia leading to syncope and sudden cardiac death at a young age. This disease cell model belongs to CPVT1, an autosomal dominant mutations (Q2311D, also called c.6933G>C) occur in the RYR2 gene. Generating pluripotent stem cells from dermal fibroblasts, then differentiate into cardiac myocytes. This disease cell model provides a platform to explore disease mechanisms in human genetic cardiac disorders.
| Specifications | |
|---|---|
| Organ System | Cardiovascular System |
| Disease | CPVT1 |
| Target Gene | RYR2 |
| Gene Function | Ryanodine receptor type 2 gene (RYR2) is a mediator of calcium release in the sarcoplasmic reticulum (SR). |
| Mutation | Q2311D (c.6933G>C) |
| Phenotype | Delayed afterdepolarisations (DADs) at rest and upon adrenergic stimulation |
| Source | Dermal fibroblasts |
| Cellular Assays | Whole-cell patch clamp techniques, immunohistochemical analysis, western blot analysis |
For Research Use Only. Not For Clinical Use.
